世界の頭蓋内ステント市場2022-2030:用途別(頭蓋内狭窄、脳動脈瘤)、製品別、エンドユーザー別、地域別

【英語タイトル】Intracranial Stents Total Addressable Market Size, Share & Trends Analysis Report By Application (Intracranial Stenosis, Brain Aneurysm), By Product, By End User, By Region, And Segment Forecasts, 2022 - 2030

Grand View Researchが出版した調査資料(GV22MY092)・商品コード:GV22MY092
・発行会社(調査会社):Grand View Research
・発行日:2022年4月25日
・ページ数:136
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(3営業日)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥880,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,028,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,324,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

グランドビューリサーチ社は、世界の頭蓋内ステント市場規模が2022年から2030年の間に年平均4.8%成長し、2030年までに41億ドルに達すると予測しています。本調査資料は、頭蓋内ステントの世界市場について分析し、調査手法・範囲、エグゼクティブサマリー、産業見通し、新型コロナウイルス感染症の影響分析、製品別(塞栓コイルサポート型頭蓋内ステント、自己拡張型ステント、その他)分析、用途別(頭蓋内狭窄、脳動脈瘤、その他)分析、エンドユーザー別(病院、外来手術センター、その他)分析、地域別分析、競争状況など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・産業見通し
・新型コロナウイルス感染症の影響分析
・世界の頭蓋内ステント市場規模:製品別(塞栓コイルサポート型頭蓋内ステント、自己拡張型ステント、その他)
・世界の頭蓋内ステント市場規模:用途別(頭蓋内狭窄、脳動脈瘤、その他)
・世界の頭蓋内ステント市場規模:エンドユーザー別(病院、外来手術センター、その他)
・世界の頭蓋内ステント市場規模:地域別
・競争状況

Intracranial Stents Total Addressable Market Growth & Trends

The global intracranial stents total addressable market size is anticipated to reach USD 4.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 4.8% from 2022 to 2030. Increasing product developments, rising prevalence of intracranial disorders, growing awareness among the general public, and supportive initiatives undertaken by public and private healthcare organizations are some of the key factors fueling the market. The Brain Foundation in Australia, for instance, supports the funding of quality research in neurological diseases, disorders, and injuries, to help advance diagnoses and treatments, improving patient outcomes.

The COVID-19 pandemic has adversely affected the number of elective surgeries during 2020 and 2021. The pandemic has affected market players and consumers in different ways, such as moving businesses online and restricted access to healthcare providers. Supply chain disruptions and operational hurdles were observed due to changing policies and restrictions during the pandemic. The disease outbreak has had a major impact on the treatment of stroke. Numerous reports have emphasized on a decline in the rate of hospital admissions for medical emergencies such as stroke or myocardial infarction. For instance, 12,546 patients were hospitalized between January and September 2020 for carotid artery surgery in France. This figure was 9.8% lower than the same period in the three preceding years (2017-2019)

Rapid adoption of novel technologies and emerging treatment options, increasing clinical trials, and strategic initiatives undertaken by key market players are factors expected to propel the market in the coming years. Acandis, headquartered in Germany, offers the Credo stent for treatment of intracranial stenosis. Credo is a self-expanding nitinol stent suitable for vessels within a diameter range of 2.0-4.5 mm. In August 2018, Cerenovus, part of Johnson & Johnson received CE mark for its BRAVO Flow Diverter intended for the treatment of intracranial aneurysms, in Europe. This enabled the company to commercialize the product.

Asia Pacific held the leading share of the market in 2021 owing to the presence of a large patient population, key companies, the prevalence of risk factors such as atherosclerosis, and improving healthcare infrastructure. The Asian-Pacific Society of Atherosclerosis and Vascular Diseases provides a forum highlighting similarities and differences of the disease across the region. It also supports regional collaboration on common research interests. According to the UN Department of Economics and Social Affairs, population in Asia was estimated at 4.64 billion in 2020, which increased to 4.67 billion in 2021.

Intracranial Stents Total Addressable Market Report Highlights

• The market was valued at USD 2.7 billion in 2021 and is expected to witness a CAGR of 4.8% during the forecast period

• Increasing incidence of intracranial disorders, technological advancements, and strategic initiatives by key companies are expected to drive the market growth in the near future

• On the basis of product, self-expanding stents accounted for the largest revenue share in 2021

• The balloon-expanding and other stents segment dominated the market in 2021. This is owing to growing R&D and adoption of flow diverter devices and drug-eluting stents

• Intracranial stenosis, on the other hand, held the dominant share in terms of applications

• The brain aneurysm segment is expected to grow the fastest over the forecast period. The rising number of people suffering from intracranial disorders and growing preference for minimally invasive surgeries are anticipated to fuel market growth

• The hospitals segment held the largest revenue share in 2021

• Asia Pacific contributed to the highest market share by region in 2021 while North America is projected to grow the fastest over the forecast period

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Research Methodology & Scope
1.1 Market Segmentation & Scope
1.2 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.5 Purchased Database:
1.6 Gvr’s Internal Database
1.7 Secondary Sources
1.8 Primary Research:
1.9 Details Of Primary Research
1.10 Information Or Data Analysis
1.11 Data Analysis Models
1.12 Market Formulation & Validation
1.13 Model Details
1.13.1 Total Addressable Market
1.13.1.1 Estimating The Number Of Cases Requiring Intracranial Stenting
1.13.1.2 Estimating The Intracranial Stents Tam
1.13.2 Estimating Asp By Product Segments At Global And Regional Levels (2021)
1.13.3 Estimating Total Number Of Units Sold At Global And Regional Levels
1.14 List Of Secondary Sources
Chapter 2. Executive Summary
2.1 Intracranial Stents Total Addressable Market Summary, 2021
Chapter 3. Intracranial Stents: Industry Outlook
3.1 Parent Market Outlook
3.2 Ancillary Market Outlook
3.3 Penetration & Growth Prospect Mapping
3.4 Market Dynamics
3.5 Market Driver Analysis
3.6 Market Restraint Analysis
3.7 Porter’s Five Forces Analysis
3.7.1 Bargaining Power Of Suppliers:
3.7.2 Bargaining Power Of Buyers:
3.7.3 Threat Of Substitutes:
3.7.4 Threat Of New Entrants:
3.7.5 Competitive Rivalry:
3.8 Pestle Analysis (Political & Legal, Economic, Social, Technological, And Environmental Landscape)
3.8.1 Political/Legal Landscape
3.8.2 Economic Landscape
3.8.3 Social Landscape
3.8.4 Technology Landscape
3.8.5 Environment Landscape
3.9 Regulatory Framework
3.10 Technology Overview
3.11 Product Pipeline Analysis
3.12 Estimated Number Of Cases Requiring Intracranial Stenting At Global And Regional Levels
3.13 Estimated Cost Of Procedure By Application
3.14 Total Estimated Number Of Units Sold At Global And Regional Levels
3.15 Estimated Asps By Product Segments At Global And Regional Levels (2021)
Chapter 4. Covid-19 Impact Analysis
4.1 Impact Of Covid-19
4.1.1 Current And Future Impact Analysis
4.1.2 Future Impact Analysis
4.1.3 Impact On Market Players
Chapter 5. Intracranial Stents Total Addressable Market: Product Estimates & Trend Analysis
5.1 Product Market Share Analysis, 2021 & 2030
5.2 Product Dashboard
5.3 Embolization Coil Support Intracranial Stents
5.3.1 Embolization Coil Support Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
5.4 Self-Expanding Stents
5.4.1 Self-Expanding Stents Market Estimates And Forecasts, 2017 – 2030 (USD Million)
5.5 Other Products
5.5.1 Others Market Estimates And Forecasts, 2017 – 2030 (USD Million)
5.5.2 Venous Sinus Stents
5.5.2.1 Adoption Trends Of Venous Sinus Stenting
5.5.2.2 Venous Sinus Stents Market Estimates And Forecasts, 2017 – 2030 (USD Million)
5.5.3 Balloon-Expanding & Other Stents
5.5.3.1 Balloon-Expanding & Other Stents Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 6. Intracranial Stents Total Addressable Market: Application Estimates & Trend Analysis
6.1 Application Market Share Analysis, 2021 & 2030
6.2 Application Dashboard
6.3 Intracranial Stenosis
6.3.1 Intracranial Stenosis Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.4 Brain Aneurysm
6.4.1 Brain Aneurysm Market Estimates And Forecasts, 2017 – 2030 (USD Million)
6.5 Others (Iih Etc.)
6.5.1 Others Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 7. Intracranial Stents Total Addressable Market: End-User Estimates & Trend Analysis
7.1 End-User Market Share Analysis, 2021 & 2030
7.2 End-User Dashboard
7.3 Hospitals
7.3.1 Hospitals Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4 Ambulatory Surgical Centers
7.4.1 Ambulatory Surgical Centers Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.5 Other End-Users
7.5.1 Other End-Users Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 8. Intracranial Stents Total Addressable Market: Regional Estimates & Trend Analysis
8.1 Regional Market Snapshot
8.2 Region Market Share Analysis, 2021 & 2030
8.3 North America
8.3.1 North America Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4 Europe
8.4.1 Europe Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4.2 U.K.
8.4.2.1 U.K. Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030(USD Million)
8.4.3 Germany
8.4.3.1 Germany Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4.4 France
8.4.4.1 France Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4.5 Italy
8.4.5.1 Italy Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.4.6 Spain
8.4.6.1 Spain Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5 Asia Pacific
8.5.1 Asia Pacific Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.2 Japan
8.5.2.1 Japan Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.3 China
8.5.3.1 China Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.4 India
8.5.4.1 India Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.5 Australia
8.5.5.1 Australia Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.5.6 South Korea
8.5.6.1 South Korea Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6 Latin America
8.6.1 Latin America Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.2 Mexico
8.6.2.1 Mexico Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.3 Brazil
8.6.3.1 Brazil Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.6.4 Argentina
8.6.4.1 Argentina Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.7 Middle East & Africa (MEA)
8.7.1 Mea Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.7.2 South Africa
8.7.2.1 South Africa Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1 Company Profiles
9.1.1 Optimed Medizinische Instrumente Gmbh
9.1.1.1 Company Overview
9.1.1.2 Financial Performance
9.1.1.3 Product Benchmarking
9.1.2 Medtronic
9.1.2.1 Company Overview
9.1.2.2 Financial Performance
9.1.2.3 Product Benchmarking
9.1.2.4 Strategic Initiatives
9.1.3 Acandis Gmbh
9.1.3.1 Company Overview
9.1.3.2 Financial Performance
9.1.3.3 Product Benchmarking
9.1.4 Microport Scientific Corporation
9.1.4.1 Company Overview
9.1.4.2 Financial Performance
9.1.4.3 Product Benchmarking
9.1.4.4 Strategic Initiatives
9.1.5 Microvention Inc.
9.1.5.1 Company Overview
9.1.5.2 Financial Performance
9.1.5.3 Product Benchmarking
9.1.5.4 Strategic Initiatives
9.1.6 Cerenovus (Johnson & Johnson)
9.1.6.1 Company Overview
9.1.6.2 Financial Performance
9.1.6.3 Product Benchmarking
9.1.6.4 Strategic Initiatives
9.1.7 Sino Medical Sciences Technology Inc.
9.1.7.1 Company Overview
9.1.7.2 Financial Performance
9.1.7.3 Product Benchmarking
9.1.7.4 Strategic Initiatives
9.1.8 Stryker
9.1.8.1 Company Overview
9.1.8.2 Financial Performance
9.1.8.3 Product Benchmarking
9.1.8.4 Strategic Initiatives
9.1.9 Abbott
9.1.9.1 Company Overview
9.1.9.2 Financial Performance
9.1.9.3 Product Benchmarking
9.1.9.4 Strategic Initiatives
9.1.10 Balt
9.1.10.1 Company Overview
9.1.10.2 Financial Performance
9.1.10.3 Product Benchmarking
9.2 Market Participation Categorization
9.3 Company Market Share Analysis, 2021
9.4 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Alliances)
9.5 Synergy Analysis: Major Deals & Strategic Alliances
9.6 List Of Companies

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of Key companies
TABLE 3 North America Intracranial Stents total addressable market, by country, 2017 - 2030 (USD Million)
TABLE 4 North America Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 5 North America Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 6 North America Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 7 U.S. Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 8 U.S. Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 9 U.S. Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 10 Canada Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 11 Canada Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 12 Canada Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 13 Europe Intracranial Stents total addressable market, by country, 2017 - 2030 (USD Million)
TABLE 14 Europe Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 15 Europe Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 16 Europe Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 17 U.K. Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 18 U.K. Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 19 U.K. Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 20 Germany Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 21 Germany Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 22 Germany Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 23 France Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 24 France Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 25 France Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 26 Italy Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 27 Italy Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 28 Italy Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 29 Spain Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 30 Spain Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 31 Spain Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 32 Asia Pacific Intracranial Stents total addressable market, by country, 2017 - 2030 (USD Million)
TABLE 33 Asia Pacific Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 34 Asia Pacific Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 35 Asia Pacific Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 36 China Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 37 China Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 38 China Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 39 Japan Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 40 Japan Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 41 Japan Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 42 India Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 43 India Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 44 India Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 45 Australia Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 46 Australia Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 47 Australia Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 48 South Korea Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 49 South Korea Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 50 South Korea Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 51 Latin America Intracranial Stents total addressable market, by country, 2017 - 2030 (USD Million)
TABLE 52 Latin America Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 53 Latin America Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 54 Latin America Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 55 Brazil Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 56 Brazil Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 57 Brazil Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 58 Mexico Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 59 Mexico Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 60 Mexico Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 61 Argentina Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 62 Argentina Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 63 Argentina Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 64 MEA Intracranial Stents total addressable market, by country, 2017 - 2030 (USD Million)
TABLE 65 MEA Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 66 MEA Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 67 MEA Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 68 South Africa Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 69 South Africa Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 70 South Africa Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 71 Saudi Arabia Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 72 Saudi Arabia Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 73 Saudi Arabia Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 74 Global Intracranial Stents total addressable market, by region, 2017 - 2030 (USD Million)
TABLE 75 Global Intracranial Stents total addressable market, by product, 2017 - 2030 (USD Million)
TABLE 76 Global Intracranial Stents total addressable market, by end user, 2017 - 2030 (USD Million)
TABLE 77 Global Intracranial Stents total addressable market, by application, 2017 - 2030 (USD Million)
TABLE 78 Product Pipeline Analysis
TABLE 79 Estimated number of cases requiring intracranial stenting (in millions), 2021
TABLE 80 Estimated cost of Procedure by Application, 2021
TABLE 81 Estimated number of units sold (by region), 2021
TABLE 82 Estimated ASPs by product segments (Global and Regional), 2021

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Intracranial Stents Market-TAM analysis
Fig. 10 Methodology for estimating the number of cases requiring intracranial stents
Fig. 11 Methodology for estimating ASP by product segment & regions
Fig. 12 Methodology for estimating total number of units sold, 2021
Fig. 13 Intracranial Stents TAM snapshot, 2021 (USD Million)
Fig. 14 Parent market outlook
Fig. 15 Ancillary market outlook
Fig. 16 Penetration & growth prospect mapping by end user, 2021
Fig. 17 Market trends & outlook
Fig. 18 Market driver relevance analysis (Current & future impact)
Fig. 19 Market restraint relevance analysis (Current & future impact)
Fig. 20 COVID-19 confirmed cases around the world
Fig. 21 Intracranial Stents total addressable market: Product movement analysis
Fig. 22 Intracranial Stents Product dashboard (USD million)
Fig. 23 Global Embolization Coil Support Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 24 Global Self-Expanding Stents market, 2017 - 2030 (USD Million)
Fig. 25 Others market, 2017 - 2030 (USD Million)
Fig. 26 Global Venous Sinus Stents market, 2017 - 2030 (USD Million)
Fig. 27 Global Balloon-expanding & Other stents market, 2017 - 2030 (USD Million)
Fig. 28 Intracranial Stents total addressable market: Application movement analysis
Fig. 29 Intracranial Stents Application dashboard (USD million)
Fig. 30 Global Intracranial Stenosis market, 2017 - 2030 (USD Million)
Fig. 31 Global Brain Aneurysm market, 2017 - 2030 (USD Million)
Fig. 32 Others market, 2017 - 2030 (USD Million)
Fig. 33 Intracranial Stents total addressable market: End-user movement analysis
Fig. 34 Intracranial Stents End-user dashboard (USD million)
Fig. 35 Global hospitals market, 2017 - 2030 (USD Million)
Fig. 36 Global ambulatory surgical centers market, 2017 - 2030 (USD Million)
Fig. 37 Other end-users market, 2017 - 2030 (USD Million)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional outlook, 2021 & 2030
Fig. 40 North America Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 41 U.S. Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 42 Canada Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 43 Europe Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 44 U.K. Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 45 Germany Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 46 France Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 47 Italy Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 48 Spain Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 49 Asia Pacific Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 50 Japan Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 51 China Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 52 India Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 53 Australia Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 54 South Korea Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 55 Latin America Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 56 Mexico Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 57 Brazil Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 58 Argentina Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 59 MEA Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 60 South Africa Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 61 Saudi Arabia Intracranial Stents total addressable market, 2017 - 2030 (USD Million)
Fig. 62 Market participation categorization
Fig. 63 Estimated Company market share, 2021
Fig. 64 Company market position analysis
Fig. 65 Synergy Analysis: Major Deals & Strategic Alliances

★調査レポート[世界の頭蓋内ステント市場2022-2030:用途別(頭蓋内狭窄、脳動脈瘤)、製品別、エンドユーザー別、地域別] (コード:GV22MY092)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の頭蓋内ステント市場2022-2030:用途別(頭蓋内狭窄、脳動脈瘤)、製品別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆